-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-07-15
Values as of: 2019-07-15
The investment seeks to track the performance (before fees and expenses) of its target index, the FTSE US Qual/Vol/Yield Factor 5% Capped Index. The underlying index is designed to measure the performance of publicly-listed large-capitalization and mid-capitalization dividend-paying issuers in the United States that meet certain market capitalization, liquidity, high quality, low volatility and dividend yield thresholds, as determined by FTSE-Russell (the "index provider"). Under normal market conditions, the fund will invest at least 80% of its total assets in the components of the underlying index.
Company Website : www.quant-shares.com
Currency: USD
Country : USA
Inception Date: 14/07/2015
Primary Benchmark: FTSE USA Qual/Vol/Yd Fctr5%Capped TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.49%
Management Expense Ratio: 0.48 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
CVE | Cenovus Energy Inc | 3.99 % |
EMMA | Emmaus Life Sciences Inc | 3.42 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
+0.01 (+0.05%) |
USD 65.72B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
-0.02 (-0.04%) |
USD 32.78B |
LCR | Leuthold Core ETF | 0.00 % |
-0.06 (-0.17%) |
USD 32.52B |
DTB | DTB | 0.00 % |
+0.02 (+0.11%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
-0.12 (-0.40%) |
USD 26.11B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
N/A |
USD 22.47B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.03 (+0.03%) |
USD 18.58B |
TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
-0.33 (-1.05%) |
USD 16.23B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.27 (+0.70%) |
USD 10.15B |
AVUV | Avantis® U.S. Small Cap Value.. | 0.00 % |
+1.11 (+1.28%) |
USD 10.05B |
N/A
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 16.16% | 66% | D+ | 60% | D- | ||
Dividend Return | 0.88% | 37% | F | 25% | F | ||
Total Return | 17.03% | 65% | D | 58% | F | ||
Trailing 12 Months | |||||||
Capital Gain | 10.92% | 90% | A- | 81% | B- | ||
Dividend Return | 2.49% | 67% | D+ | 48% | F | ||
Total Return | 13.41% | 91% | A- | 80% | B- | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | F | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | N/A | N/A | N/A | N/A | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 6.53% | 74% | C | 59% | D- | ||
Dividend Return | 8.48% | 59% | D- | 59% | D- | ||
Total Return | 1.95% | 36% | F | 49% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 6.77% | 86% | B+ | 92% | A | ||
Risk Adjusted Return | 125.17% | 91% | A- | 97% | N/A | ||
Market Capitalization | 0.31B | 72% | C | 44% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The company had positive total cash flow in the most recent four quarters.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.